一决高下：哪种纤维化筛查工具对非酒精性脂肪性肝病最可靠？ - Suppr

Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?

作者信息

Bou Daher Halim, Manka Paul, Syn Wing-Kin

机构信息

Department of Internal Medicine, Saint Louis University, St Louis, MO, USA.

Department of Internal Medicine, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.

出版信息

Dig Dis Sci. 2023 Jun;68(6):2217-2220. doi: 10.1007/s10620-023-07899-0. Epub 2023 Mar 22.

DOI:10.1007/s10620-023-07899-0

PMID:36947290

Abstract

摘要

相似文献

Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?一决高下：哪种纤维化筛查工具对非酒精性脂肪性肝病最可靠？

Dig Dis Sci. 2023 Jun;68(6):2217-2220. doi: 10.1007/s10620-023-07899-0. Epub 2023 Mar 22.

Letter to the editor: diagnosing fibrosis and cirrhosis in nonalcoholic fatty liver disease using machine learning models.致编辑的信：使用机器学习模型诊断非酒精性脂肪性肝病中的纤维化和肝硬化

Hepatology. 2023 May 1;77(5):E103-E104. doi: 10.1097/HEP.0000000000000209. Epub 2023 Jan 3.

Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?非酒精性脂肪性肝病的无创诊断：我们做到了吗？

Metabolism. 2016 Aug;65(8):1087-95. doi: 10.1016/j.metabol.2016.01.013. Epub 2016 Feb 2.

Monocyte phenotypic liquid biopsy for NASH and liver fibrosis diagnosis: a new kid on the block.用于非酒精性脂肪性肝炎和肝纤维化诊断的单核细胞表型液体活检：初来乍到的新方法

Gut. 2023 Dec 7;73(1):10-11. doi: 10.1136/gutjnl-2022-328189.

Diabetes Liver Fibrosis Score to Detect Advanced Fibrosis in Diabetics with Nonalcoholic Fatty Liver Disease.糖尿病肝纤维化评分用于检测非酒精性脂肪性肝病糖尿病患者的晚期纤维化

Clin Gastroenterol Hepatol. 2022 Mar;20(3):e624-e626. doi: 10.1016/j.cgh.2021.01.010. Epub 2021 Jan 9.

Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的诊断和评估，包括无创生物标志物和瞬时弹性成像。

Clin Liver Dis. 2018 Feb;22(1):73-92. doi: 10.1016/j.cld.2017.08.004.

Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India.血清铁蛋白水平可预测印度非酒精性脂肪性肝病患者的组织学严重程度。

Indian J Gastroenterol. 2015 May;34(3):200-8. doi: 10.1007/s12664-015-0572-5. Epub 2015 Jun 25.

Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的临床表现和患者评估。

Clin Liver Dis. 2016 May;20(2):277-92. doi: 10.1016/j.cld.2015.10.006. Epub 2016 Feb 17.

The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患儿肝纤维化评分的评估

Dig Dis Sci. 2015 May;60(5):1440-7. doi: 10.1007/s10620-014-3494-7. Epub 2014 Dec 25.

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的无创纤维化评估

Chin Med J (Engl). 2020 Nov 20;133(22):2743-2745. doi: 10.1097/CM9.0000000000000989.

引用本文的文献

Integrating liver endpoints in clinical trials of cardiovascular and kidney disease.将肝脏终点纳入心血管和肾脏疾病临床试验中。

Nat Med. 2024 Sep;30(9):2423-2431. doi: 10.1038/s41591-024-03223-z. Epub 2024 Sep 3.

本文引用的文献

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.美国临床内分泌学会临床实践指南：制定糖尿病综合护理计划-2022 更新版。

Endocr Pract. 2022 Oct;28(10):923-1049. doi: 10.1016/j.eprac.2022.08.002. Epub 2022 Aug 11.

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者风险分层与管理的临床护理路径。

Gastroenterology. 2021 Nov;161(5):1657-1669. doi: 10.1053/j.gastro.2021.07.049. Epub 2021 Sep 20.

Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.美国2型糖尿病患者非酒精性脂肪性肝病筛查具有成本效益：一项全面的成本效用分析。

Gastroenterology. 2020 Nov;159(5):1985-1987.e4. doi: 10.1053/j.gastro.2020.07.050. Epub 2020 Aug 5.

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.基于 III 期 STELLAR 临床试验结果：塞利昔布治疗 NASH 相关桥接纤维化或代偿期肝硬化患者。

J Hepatol. 2020 Jul;73(1):26-39. doi: 10.1016/j.jhep.2020.02.027. Epub 2020 Mar 6.

Advances in non-invasive assessment of hepatic fibrosis.肝纤维化无创评估的进展。

Gut. 2020 Jul;69(7):1343-1352. doi: 10.1136/gutjnl-2018-317593. Epub 2020 Feb 17.

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.纤维化分期与非酒精性脂肪性肝病患者结局的相关性：系统评价和荟萃分析。

Gastroenterology. 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4.

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.年龄作为晚期非酒精性脂肪性肝病纤维化准确无创诊断的混杂因素。

Am J Gastroenterol. 2017 May;112(5):740-751. doi: 10.1038/ajg.2016.453. Epub 2016 Oct 11.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中血液纤维化检测和 FibroScan 肝硬度测量的诊断准确性和预后意义。

J Hepatol. 2016 Sep;65(3):570-8. doi: 10.1016/j.jhep.2016.04.023. Epub 2016 May 2.

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。

Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.磁共振弹性成像与八项临床预测规则对经活检证实的非酒精性脂肪性肝病晚期纤维化进行无创诊断的比较诊断准确性：一项前瞻性研究。

Aliment Pharmacol Ther. 2015 Jun;41(12):1271-80. doi: 10.1111/apt.13196. Epub 2015 Apr 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献